by Truveta Staff | Aug 22, 2023 | Technology
RSV season, which typically starts in fall and peaks in winter, could look very different this year. With newly approved vaccines for older adults and pregnant women and an immunization for infants poised to roll out, public health experts are optimistic about...
by Truveta Staff | Jul 28, 2023 | Technology
Scientists from the Institute for Systems Biology (ISB) have published new research in the JMIR Public Health and Surveillance journal. The work explores the National Institute of Health (NIH) recommendation for prophylactic anticoagulant use for pregnant patients...
by Truveta Staff | May 19, 2023 | Technology
The Wall Street Journal recently published a story, If Your Toddler Isn’t Talking Yet, the Pandemic Might Be to Blame, based on a new pre-print published by Truveta Research on MedRxiv, which investigated speech delays in children under age 5 as an unexpected outcome...
by Truveta Staff | Jan 18, 2023 | News, Research
In November, Truveta Research shared their findings on racial disparities in treatment and hospitalization during different periods of time of the COVID-19 pandemic. Now, the peer-reviewed paper, “Racial inequality in COVID treatment and in-hospital length of...
by Truveta Staff | Nov 10, 2022 | Research
Earlier this year, Truveta Research presented insights from the start of the pandemic, with a focus on those impacted by COVID-19. Analyses from their insights can help researchers better understand healthcare and outcomes across de-identified populations. The second...